Literature DB >> 21572890

Tacrolimus (FK506)-Associated Renal Pathology.

Parmjeet S Randhawa1, Thomas E Starzl, Anthony Jake Demetris.   

Abstract

Entities:  

Year:  1997        PMID： 21572890      PMCID： PMC3092646          DOI： 10.1097/00125480-199707000-00032

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN： 1072-4109            Impact factor:   3.875


× No keyword cloud information.
  107 in total

1.  The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver.

Authors:  K Abu-Elmagd; J J Fung; M Alessiani; A Jain; R Venkataramanan; V S Warty; S Takaya; S Todo; W D Shannon; T E Starzl
Journal:  Transplantation       Date:  1991-07       Impact factor: 4.939

2.  FK506-associated thrombotic thrombocytopenic purpura.

Authors:  M J Holman; T A Gonwa; B Cooper; B S Husberg; R M Goldstein; J F Gibbs; G B Klintmalm
Journal:  Transplantation       Date:  1993-01       Impact factor: 4.939

3.  Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids.

Authors:  S Todo; A J Demetris; Y Ueda; O Imventarza; K Okuda; A Casavilla; S Cemaj; A Ghalab; V Mazzaferro; B S Rhoe
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

4.  Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506.

Authors:  J McCauley; O Bronsther; J Fung; S Todo; T E Starzl
Journal:  Lancet       Date:  1989 Dec 23-30       Impact factor: 79.321

5.  Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation.

Authors:  R P Kershner; W E Fitzsimmons
Journal:  Transplantation       Date:  1996-10-15       Impact factor: 4.939

6.  Kidney transplantation under FK 506.

Authors:  T E Starzl; J Fung; M Jordan; R Shapiro; A Tzakis; J McCauley; J Johnston; Y Iwaki; A Jain; M Alessiani
Journal:  JAMA       Date:  1990-07-04       Impact factor: 56.272

7.  Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine.

Authors:  K Svenson; S O Bohman; R Hällgren
Journal:  Arch Intern Med       Date:  1986-10

8.  The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome.

Authors:  D B Kaufman; B Kaplan; Y S Kanwar; M Abecassis; F P Stuart
Journal:  Transplantation       Date:  1995-06-27       Impact factor: 4.939

Review 9.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

10.  Morphological and functional renal effects of long-term low-dose cyclosporin A treatment in patients with rheumatoid arthritis.

Authors:  S Sund; O Førre; K J Berg; T K Kvien; T Hovig
Journal:  Clin Nephrol       Date:  1994-01       Impact factor: 0.975
View more
  14 in total

1.  Tacrolimus Protects against Age-Associated Microstructural Changes in the Beagle Brain.

Authors:  Hamsanandini Radhakrishnan; Margo F Ubele; Stephanie M Krumholz; Kathy Boaz; Jennifer L Mefford; Erin Denhart Jones; Beverly Meacham; Jeffrey Smiley; László G Puskás; David K Powell; Christopher M Norris; Craig E L Stark; Elizabeth Head
Journal:  J Neurosci       Date:  2021-05-05       Impact factor: 6.167

2.  A Higher Foci Density of Interstitial Fibrosis and Tubular Atrophy Predicts Progressive CKD after a Radical Nephrectomy for Tumor.

Authors:  Luisa Ricaurte Archila; Aleksandar Denic; Aidan F Mullan; Ramya Narasimhan; Marija Bogojevic; R Houston Thompson; Bradley C Leibovich; S Jeson Sangaralingham; Maxwell L Smith; Mariam P Alexander; Andrew D Rule
Journal:  J Am Soc Nephrol       Date:  2021-06-18       Impact factor: 14.978

3.  A Systems Toxicology Approach for the Prediction of Kidney Toxicity and Its Mechanisms In Vitro.

Authors:  Susanne Ramm; Petar Todorov; Vidya Chandrasekaran; Anders Dohlman; Maria B Monteiro; Mira Pavkovic; Jeremy Muhlich; Harish Shankaran; William W Chen; Jerome T Mettetal; Vishal S Vaidya
Journal:  Toxicol Sci       Date:  2019-05-01       Impact factor: 4.849

4.  Posterior Reversible Encephalopathy Syndrome after Heart Transplantation: Diagnosis and Immunosuppressive Therapy.

Authors:  Aniruddh Kapoor; Emma Birks; Andrew Lenneman; Kelly McCants
Journal:  Tex Heart Inst J       Date:  2017-06-01

5.  Olmesartan attenuates tacrolimus-induced biochemical and ultrastructural changes in rat kidney tissue.

Authors:  Naif O Al-Harbi; Faisal Imam; Mohammed M Al-Harbi; Muzaffar Iqbal; Ahmed Nadeem; Mohammed M Sayed-Ahmed; Ali D Alabidy; Ali F Almukhallafi
Journal:  Biomed Res Int       Date:  2014-05-28       Impact factor: 3.411

6.  An Elastomeric Polymer Matrix, PEUU-Tac, Delivers Bioactive Tacrolimus Transdurally to the CNS in Rat.

Authors:  Yolandi van der Merwe; Anne E Faust; Ian Conner; Xinzhu Gu; Firuz Feturi; Wenchen Zhao; Bianca Leonard; Souvik Roy; Vijay S Gorantla; Raman Venkataramanan; Kia M Washington; William R Wagner; Michael B Steketee
Journal:  EBioMedicine       Date:  2017-11-24       Impact factor: 8.143

Review 7.  BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.

Authors:  Mar Orriols; Maria Catalina Gomez-Puerto; Peter Ten Dijke
Journal:  Cell Mol Life Sci       Date:  2017-04-26       Impact factor: 9.261

8.  Protective effect of Korean Red Ginseng against FK506-induced damage in LLC-PK1 cells.

Authors:  Dahae Lee; Ki Sung Kang; Jae Sik Yu; Jung-Yoon Woo; Gwi Seo Hwang; Dae-Woon Eom; Seung-Hoon Baek; Hye Lim Lee; Ki Hyun Kim; Noriko Yamabe
Journal:  J Ginseng Res       Date:  2016-05-24       Impact factor: 6.060

9.  Severe unexplained relative hypotension and bradycardia in the emergency department.

Authors:  Shivam Kharod; Candice Norman; Matthew Ryan; Robyn M Hoelle
Journal:  Case Rep Emerg Med       Date:  2014-03-05

10.  Immunosuppressant drug tacrolimus induced mitochondrial nephrotoxicity, modified PCNA and Bcl-2 expression attenuated by Ocimum basilicum L. in CD1 mice.

Authors:  Atif Abdulwahab A Oyouni; Shalini Saggu; Ehab Tousson; Hasibur Rehman
Journal:  Toxicol Rep       Date:  2018-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.